Search
for
Sort by
Research 31–60 of 79
- Efficacy of Percutaneous Superficial Temporal Arterial Hyaluronidase Injection for Hyaluronic Acid Filler–Induced Necrosis of Frontotemporal Skin and/or the Ipsilateral Scalp With Subsequent Alopecia
- Children with trichotillomania in COVID‐19 outbreak
- The spectrum of nephrocutaneous diseases and associations
- Indirect skin sign of COVID‐19 days: Striae rubrae
- Telogen Effluvium after SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms
- Contact dermatitis to phenol‐formaldehyde resin in two plywood factory workers
- LETTERS TO THE EDITOR
- The Impact of Covid-19 Pandemic on the Clinical Course of Pediatric Skin Disorders: A Cross-Sectional Study
- Genital Dermatology
- Subject Index
- Book Reviews
- ANNOUNCEMENTS
- Cutaneous manifestations associated with COVID-19 infection at a university hospital in eastern China
- Heterogeneous red–white discoloration of the nail bed and distal onycholysis in a patient with COVID‐19
- Telogen effluvium, Beau lines, and acral peeling associated with COVID-19 infection
- The hair growth promoting effect of 4-O-methylhonokiol
- Cutaneous manifestations of COVID-19: a case report and review of the literature
- Advances in Dermatology
- General Dermatology
- Persistent Panniculitis in Dermatomyositis
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Issue Information
- Eflúvio telógeno pós-infecção por Covid-19: uma revisão narrativa / Telogen effluvium post Covid-19 infection: a narrative review
- The COVID-19 pandemic and its skin effects
- Cutaneous Involvement in Systemic Lupus Erythematosus: A Review for the Rheumatologist
- Transverse Leukonychia and Beau Lines Following COVID-19 Vaccination
- Patient Recovery from COVID-19 Infections: Follow-Up of Hair, Nail, and Cutaneous Manifestations
- COVID-19 infection is a major cause of acute telogen effluvium
- Sildenafil: Looking Beyond Erectile Dysfunction: A Dermatological Perspective
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience